Amanta Healthcare Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

Technical Momentum and Price Action

On 12 Jun 2026, Amanta Healthcare Ltd’s stock price closed at ₹149.05, up from the previous close of ₹140.75, marking a daily gain of 5.9%. The intraday range was notable, with a low of ₹140.20 and a high reaching the 52-week peak of ₹164.65. This surge underscores a strong buying interest, pushing the stock closer to its annual high of ₹164.65, well above its 52-week low of ₹93.10.

The stock’s upward momentum is further validated by its recent returns relative to the benchmark Sensex. Over the past week, Amanta Healthcare delivered an impressive 11.82% return, contrasting sharply with the Sensex’s decline of 0.71%. The one-month return stands at 9.52%, while year-to-date gains have soared to 37.12%, against the Sensex’s negative 13.36%. These figures highlight the stock’s outperformance within the Pharmaceuticals & Biotechnology sector and the broader market.

MACD and RSI Signals

The Moving Average Convergence Divergence (MACD) indicator on the weekly chart has turned bullish, signalling increasing upward momentum. This suggests that the short-term moving average has crossed above the longer-term moving average, a classic buy signal for technical traders. However, the monthly MACD remains neutral, indicating that while short-term momentum is strong, longer-term trends require further confirmation.

Conversely, the Relative Strength Index (RSI) on the weekly timeframe is bearish, implying that the stock may be experiencing some short-term overbought conditions or a potential pullback. The monthly RSI remains neutral, which tempers concerns of an extended overbought state. Investors should monitor RSI levels closely, as a sustained rise above 70 could signal overheating, while a drop below 30 might indicate undervaluation.

Bollinger Bands and Moving Averages

Bollinger Bands on the weekly chart have expanded and turned bullish, reflecting increased volatility and a strong price breakout above the upper band. This technical behaviour often precedes sustained upward trends, as it indicates strong buying pressure. The daily moving averages, although not explicitly detailed, are implied to support this bullish momentum, given the overall upgrade in technical trend from mildly bullish to bullish.

Dow Theory and Volume Indicators

Dow Theory assessments on both weekly and monthly charts confirm a bullish trend, reinforcing the positive outlook. This theory, which analyses market trends through price action and volume, suggests that Amanta Healthcare is in an established uptrend. Supporting this, the On-Balance Volume (OBV) indicator is bullish on both weekly and monthly timeframes, signalling that volume is confirming the price rise and that accumulation is likely ongoing.

Mojo Score and Rating Upgrade

Reflecting the improved technical outlook, Amanta Healthcare’s Mojo Score has risen to 51.0, earning a Mojo Grade upgrade from Sell to Hold as of 11 Jun 2026. This upgrade signals a more balanced risk-reward profile, suggesting that while the stock is not yet a strong buy, it has moved out of negative territory and is showing signs of stabilisation and potential growth. The micro-cap status of the company indicates a smaller market capitalisation, which can entail higher volatility but also greater upside potential for investors willing to accept the associated risks.

Comparative Performance and Sector Context

Within the Pharmaceuticals & Biotechnology sector, Amanta Healthcare’s recent technical improvements and price momentum stand out. The sector itself has been under pressure in recent months, but Amanta’s relative strength and technical signals suggest it is carving out a leadership position among its peers. Its year-to-date return of 37.12% starkly contrasts with the Sensex’s negative 13.36%, underscoring the stock’s resilience and appeal amid broader market weakness.

Longer-term returns for Amanta Healthcare are not available, but the Sensex’s 3-year and 5-year returns of 17.90% and 40.70% respectively provide a benchmark for potential growth trajectories. The stock’s current technical momentum could be an early indicator of a sustained uptrend that might enable it to close the gap with larger benchmarks over time.

Investor Considerations and Outlook

Investors should weigh the bullish technical signals against the cautionary RSI readings and the micro-cap nature of Amanta Healthcare. The bullish MACD, Bollinger Bands, and Dow Theory signals suggest that momentum is building, but the weekly RSI’s bearish stance warns of possible short-term volatility or consolidation. Monitoring daily moving averages and volume trends will be crucial in confirming the sustainability of this rally.

Given the recent upgrade to a Hold rating, investors might consider accumulating shares on dips while maintaining a disciplined exit strategy should momentum falter. The stock’s proximity to its 52-week high indicates strong resistance levels ahead, and profit-taking could emerge near these price points.

Summary

Amanta Healthcare Ltd’s recent technical parameter changes mark a clear shift towards bullish momentum, supported by strong weekly MACD and Bollinger Bands signals, alongside confirmation from Dow Theory and OBV indicators. Despite a bearish weekly RSI, the overall technical trend upgrade from mildly bullish to bullish, coupled with a Mojo Grade improvement to Hold, suggests a positive near-term outlook for this Pharmaceuticals & Biotechnology micro-cap.

Investors should remain vigilant for potential short-term pullbacks but can take encouragement from the stock’s outperformance relative to the Sensex and sector peers. The stock’s current price action near its 52-week high and the technical indicators point to a developing uptrend that may offer attractive opportunities for those with a medium-term investment horizon.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →